Skip to main content
Top
Published in: Journal of General Internal Medicine 4/2020

01-04-2020 | Concise Research Report

Why Do Physicians Pursue Cascades of Care After Incidental Findings? A National Survey

Authors: Ishani Ganguli, MD, MPH, Arabella L. Simpkin, MD, MMSc, Carrie H. Colla, PhD, Arlene Weissman, PhD, Alexander J. Mainor, JD, MPH, Meredith B. Rosenthal, PhD, Thomas D. Sequist, MD, MPH

Published in: Journal of General Internal Medicine | Issue 4/2020

Login to get access

Excerpt

Screening and diagnostic tests often reveal incidental findings, prompting cascades of further testing and treatment that are of uncertain value and can cause financial, physical, and psychological harms.1, 2 Like medical decisions writ large, the decision to pursue equivocal incidental findings may vary across physicians—informed not just by clinical need but also by physician factors such as training, fear of liability, discomfort with uncertainty, cost-consciousness, and perceived patient demand, or by health system factors such as malpractice laws and community norms.1, 3 Understanding how often and why doctors make these decisions would help to mitigate harms from cascades. Therefore, we surveyed a national sample of generalist physicians to explore variation in, predictors of, and motivations behind the decision to pursue equivocal incidental findings. …
Literature
1.
go back to reference Deyo RA. Cascade effects of medical technology. Annu Rev Public Heal. 2002;23:23–44.CrossRef Deyo RA. Cascade effects of medical technology. Annu Rev Public Heal. 2002;23:23–44.CrossRef
3.
go back to reference Zafar HM, Bugos EK, Langlotz CP, Frasso R. “Chasing a Ghost”: Factors that Influence Primary Care Physicians to Follow Up on Incidental Imaging Findings. Radiology. 2016;281:567–573.CrossRef Zafar HM, Bugos EK, Langlotz CP, Frasso R. “Chasing a Ghost”: Factors that Influence Primary Care Physicians to Follow Up on Incidental Imaging Findings. Radiology. 2016;281:567–573.CrossRef
4.
go back to reference Schwartz AL, Jena AB, Zaslavsky AM, McWilliams JM. Analysis of Physician Variation in Provision of Low-Value Services. JAMA Intern Med. 2019;179:16–25.CrossRef Schwartz AL, Jena AB, Zaslavsky AM, McWilliams JM. Analysis of Physician Variation in Provision of Low-Value Services. JAMA Intern Med. 2019;179:16–25.CrossRef
5.
go back to reference Rothberg MB, Class J, Bishop TF, Friderici J, Kleppel R, Lindenauer PK. The Cost of Defensive Medicine on 3 Hospital Medicine Services. JAMA Intern Med. 2014;174:1867.CrossRef Rothberg MB, Class J, Bishop TF, Friderici J, Kleppel R, Lindenauer PK. The Cost of Defensive Medicine on 3 Hospital Medicine Services. JAMA Intern Med. 2014;174:1867.CrossRef
6.
go back to reference Parchman ML, Henrikson NB, Blasi PR, et al. Taking action on overuse: Creating the culture for change. Healthcare. 2017;5:199–203.CrossRef Parchman ML, Henrikson NB, Blasi PR, et al. Taking action on overuse: Creating the culture for change. Healthcare. 2017;5:199–203.CrossRef
Metadata
Title
Why Do Physicians Pursue Cascades of Care After Incidental Findings? A National Survey
Authors
Ishani Ganguli, MD, MPH
Arabella L. Simpkin, MD, MMSc
Carrie H. Colla, PhD
Arlene Weissman, PhD
Alexander J. Mainor, JD, MPH
Meredith B. Rosenthal, PhD
Thomas D. Sequist, MD, MPH
Publication date
01-04-2020
Publisher
Springer International Publishing
Published in
Journal of General Internal Medicine / Issue 4/2020
Print ISSN: 0884-8734
Electronic ISSN: 1525-1497
DOI
https://doi.org/10.1007/s11606-019-05213-1

Other articles of this Issue 4/2020

Journal of General Internal Medicine 4/2020 Go to the issue
Live Webinar | 27-06-2024 | 18:00 (CEST)

Keynote webinar | Spotlight on medication adherence

Live: Thursday 27th June 2024, 18:00-19:30 (CEST)

WHO estimates that half of all patients worldwide are non-adherent to their prescribed medication. The consequences of poor adherence can be catastrophic, on both the individual and population level.

Join our expert panel to discover why you need to understand the drivers of non-adherence in your patients, and how you can optimize medication adherence in your clinics to drastically improve patient outcomes.

Prof. Kevin Dolgin
Prof. Florian Limbourg
Prof. Anoop Chauhan
Developed by: Springer Medicine
Obesity Clinical Trial Summary

At a glance: The STEP trials

A round-up of the STEP phase 3 clinical trials evaluating semaglutide for weight loss in people with overweight or obesity.

Developed by: Springer Medicine

Highlights from the ACC 2024 Congress

Year in Review: Pediatric cardiology

Watch Dr. Anne Marie Valente present the last year's highlights in pediatric and congenital heart disease in the official ACC.24 Year in Review session.

Year in Review: Pulmonary vascular disease

The last year's highlights in pulmonary vascular disease are presented by Dr. Jane Leopold in this official video from ACC.24.

Year in Review: Valvular heart disease

Watch Prof. William Zoghbi present the last year's highlights in valvular heart disease from the official ACC.24 Year in Review session.

Year in Review: Heart failure and cardiomyopathies

Watch this official video from ACC.24. Dr. Biykem Bozkurt discusses last year's major advances in heart failure and cardiomyopathies.